Showing 135 results
July 2022
-
Media Release
Experts encourage women with advanced breast cancer to get tested for PIK3CA mutation to improve treatment outcomes
Genetic mutations affect breast cancer prognosis, making every patient unique. It is important for patients to get tested to find out the specific mutation, and help doctors develop a personalized… -
Media Release
Philippine FDA approves Novartis advanced breast cancer treatment, alpelisib
The Philippine Food and Drug Administration (FDA) has approved alpelisib in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor positive, human…
May 2022
-
Media Release
Novartis Philippines launches PIK3CA Testing Program for Breast Cancer
Stakeholder officials signed the formal agreement to implement the Novartis PIK3CA Testing Program for advanced Breast Cancer patients. Photo shows (from left): Ms… -
Media Release
Survey reveals delayed diagnosis, heavy disease burden among Filipinos with axial spondyloarthritis
On average, Filipinos with axial spondyloarthritis (axSpA) are diagnosed 5.8 years after developing the disease. axSpA has significant functional, psychosocial and economic impact on patients,…
February 2022
-
Media Release
World Cancer Day 2022: Novartis committed to helping close the gap in cancer care
In observance of World Cancer Day, Novartis reiterated its commitment to enhancing access to innovative cancer treatments. World Cancer Day is observed on February 4 of every year. Its theme for… -
Story Education & Awareness
Asia Pacific Patient Innovation Summit: Philippines Outcome Report 2021
January 2022
-
Media Release
Indonesia, Philippines & Vietnam: Building on lessons learned to enhance eyecare services beyond COVID-19
Collaboration to Preserve Sight partners from Indonesia, Vietnam and the Philippines gathered anew in a virtual forum titled “How can 2030 In Sight support eye health beyond Covid?” Convened by… -
Media Release
Novartis Healthcare Philippines recognized as a Top Employer for the second consecutive year
Novartis Healthcare Philippines has been officially recognized by the Top Employers Institute as a Top Employer 2022 in the Philippines. To become recognized as a Top Employer, an organization… -
Media Release
IAPB, Perdami, NCSP, VRSP, FHF & Novartis join forces to provide eyecare services during the pandemic
IAPB, Novartis and their Collaboration to Preserve Sight partners came together in a virtual roundtable discussion to share lessons learned and map the way forward in providing eyecare services in…